Boryung and Lilly will co-promote the pancreatic and lung cancer treatment ‘Gemzar’
Boryung Pharmaceutical and Lilly Korea will jointly promote the pancreatic and lung cancer treatment ‘Gemzar.’
Boryung Pharmaceutical (President Tae-hong Choi) and Lilly Korea(President Paul Henry Huibers) held the co-promotion contract ceremony for ‘Gemzar (generic name: gemcitabine)’ at the Bo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
